ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.83
0.43%
US Tech 100
17,142.80
1.67%
S&P 500
5,064.20
0.91%
US Dollar vs CAD
1.36744
-0.36%
Bitcoin
58,730.59
0.85%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Revance Therapeutics Inc (RVNC)

  7. Revance Therapeutics Inc (RVNC) News

RVNC Revance Therapeutics Inc

3.77
-0.025 (-0.66%)
After Hours
Last Updated: 15:40:01
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Revance Therapeutics Inc RVNC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.025 -0.66% 3.77 15:40:01
Open Price Low Price High Price Close Price Previous Close
3.91 3.655 3.99 3.77 3.795
more quote information »

Recent News

Date Time Source Heading
5/02/202415:05BWRevance to Release First Quarter 2024 Financial Results on..
4/12/202407:00BWRevance to Present New DAXXIFY® Data at the American Academy..
3/27/202415:05BWRevance Reports Inducement Grants Under Nasdaq Listing Rule..
3/08/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:08EDGAR2Form 8-K - Current report
3/05/202416:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
3/04/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202408:25BWRevance Announces Pricing of $100.0 Million Public Offering..
3/04/202405:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
3/04/202405:37BWRevance Announces Proposed Public Offering of Common Stock
2/29/202415:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/28/202415:07EDGAR2Form 8-K - Current report
2/28/202415:05BWRevance Reports Fourth Quarter and Full Year 2023 Financial..
2/21/202407:01BWRevance to Release Fourth Quarter and Full Year 2023..
2/21/202407:00BWRevance to Participate in Upcoming Investor Conferences
2/14/202414:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202415:28EDGAR2Form 8-K - Current report
2/13/202408:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202415:04EDGAR2Form 8-K - Current report
2/02/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202407:00BWRevance Receives Permanent J-Code for DAXXIFY® and Announces..
2/01/202407:00BWRevance to Participate in the Guggenheim 6th Annual..
1/11/202405:18IHMARKETNEWSWall Street Highlights: Mastercard’s Financial Rise,..
1/08/202407:01EDGAR2Form 8-K - Current report
1/08/202407:00BWRevance Provides Corporate Update, Preliminary Fourth..
1/03/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202315:04EDGAR2Form 8-K - Current report
12/12/202304:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
11/14/202315:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/08/202315:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202315:09EDGAR2Form 8-K - Current report
11/08/202315:06BWRevance Reports Third Quarter 2023 Financial Results,..
11/08/202315:05BWRevance Appoints Erica Jordan as Chief Commercial Officer,..
11/06/202307:00BWRevance to Participate in Upcoming Investor Conferences
11/01/202307:00BWRevance to Release Third Quarter 2023 Financial Results on..
10/26/202307:00BWDAXXIFY® Becomes First Facial Injectable to be Named to..
10/24/202315:05EDGAR2Form SC 13D/A - General statement of acquisition of..
9/19/202308:01EDGAR2Form 8-K - Current report
9/19/202308:00BWRevance Provides Corporate Update at Investor Day
9/07/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202315:21EDGAR2Form 144 - Report of proposed sale of securities
9/05/202316:43EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

NASDAQ
RVNC
Revance Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved